Recommendations for the Reporting of Prostate Carcinoma

Overview

Journal Virchows Arch

Specialties Cell Biology
Molecular Biology
Pathology

Date 2007 Aug 4

PMID 17674043

Authors

Jonathan I Epstein

John Srigley

David Grignon

Peter Humphrey

Christopher Otis

Affiliations

Soon will be listed here.

References

GLEASON D, MELLINGER G . Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974; 111(1):58-64. DOI: 10.1016/s0022-5347(17)59889-4. View

Humphrey P, Walther P . Adenocarcinoma of the prostate. I. Tissue sampling considerations. Am J Clin Pathol. 1993; 99(6):746-59. DOI: 10.1093/ajcp/99.6.746. View

May F, Hartung R, Breul J . The ability of the American Joint Committee on Cancer Staging system to predict progression-free survival after radical prostatectomy. BJU Int. 2002; 88(7):702-7. DOI: 10.1046/j.1464-4096.2001.02420.x. View

Eichelberger L, Cheng L . Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma. Cancer. 2004; 100(12):2573-6. DOI: 10.1002/cncr.20305. View

Freedland S, Partin A, Epstein J, Walsh P . Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b. Cancer. 2004; 100(8):1646-9. DOI: 10.1002/cncr.20145. View

Epstein J, Allsbrook Jr W, Amin M, Egevad L . The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005; 29(9):1228-42. DOI: 10.1097/01.pas.0000173646.99337.b1. View

Amin M, Boccon-Gibod L, Egevad L, Epstein J, Humphrey P, Mikuz G . Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl. 2005; (216):20-33. DOI: 10.1080/03008880510030923. View

Grignon D, Sakr W . Pathologic staging of prostate carcinoma. What are the issues?. Cancer. 1996; 78(2):337-40. DOI: 10.1002/(SICI)1097-0142(19960715)78:2<337::AID-CNCR23>3.0.CO;2-W. View

Ohori M, Kattan M, Scardino P, Wheeler T . Radical prostatectomy for carcinoma of the prostate. Mod Pathol. 2004; 17(3):349-59. DOI: 10.1038/modpathol.3800056. View

10.

Epstein J, Herawi M . Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol. 2006; 175(3 Pt 1):820-34. DOI: 10.1016/S0022-5347(05)00337-X. View

11.

Epstein J, Amin M, Boccon-Gibod L, Egevad L, Humphrey P, Mikuz G . Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl. 2005; (216):34-63. DOI: 10.1080/03008880510030932. View

12.

Epstein J . The evaluation of radical prostatectomy specimens. Therapeutic and prognostic implications. Pathol Annu. 1991; 26 Pt 1:159-210. View